Posted:
11/13/2026, 5:56:05 AM
Location(s):
California, United States ⋅ Concord, California, United States
Experience Level(s):
Mid Level ⋅ Senior
Field(s):
Product ⋅ Sales & Account Management
Workplace Type:
On-site
Pay:
$121k–$160k/yr
About Cerus:
Cerus aims to be the global leader and trusted partner of blood centers and hospitals whose technology, services, and commitment are the lifeblood of safe and accessible blood for patients around the world.
This is a hybrid opportunity where you'll work out of our Concord office 2-3 times weekly.
Summary:
Responsible for managing lifecycle and portfolio operations for marketed INTERCEPT Blood System products. Works with cross-functional teams to plan and drive the implementation of approved product enhancements, claim extensions, labeling and configuration changes, regulatory submissions, and launches. Represents customer and commercial needs and coordinates execution across Product Management, Regulatory, Quality, R&D, Supply Chain, Service, Deployment, and Regional Marketing.
Primary Responsibilities:
Qualifications/Requirements/Skills:
Travel estimated at 10-25%, including occasional weekends and travel.
We understand that our people are essential to our success. This philosophy is revealed in our competitive benefits package, designed to improve employees’ lives both on and off the job.
Benefits plans: medical, dental, vision, domestic partner benefits, paid maternity and paternity leaves, healthcare and dependent care flexible spending, life and accidental death insurance, long-term and short-term disability insurance, matching 401(k), RSUs
Work and family: EAP, legal and financial services, health club membership discounts, tuition reimbursement
Compensation: The base salary range for this position in the selected city is $121,000-$160,000 annually. Base pay is one part of the total package to compensate and recognize employees for their work.
Website: https://www.cerus.com/
Headquarter Location: Concord, California, United States
Employee Count: 251-500
Year Founded: 1991
IPO Status: Public
Last Funding Type: Post-IPO Equity
Industries: Biotechnology ⋅ Health Care ⋅ Industrial Automation ⋅ Manufacturing ⋅ Pharmaceutical ⋅ Smart Building
Visa Sponsorship: Sponsors work visas